Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 6151 results
Sort by: relevance publication year
Showing results for ISSN matching 1474-1776

Industry concern over EU hepatotoxicity guidance

JOURNAL ARTICLE published September 2008 in Nature Reviews Drug Discovery

Authors: Bethan Hughes

https://doi.org/10.1038/nrd2677 Actions

Towards a broad-spectrum flavivirus vaccine

JOURNAL ARTICLE published February 2021 in Nature Reviews Drug Discovery

Authors: Sarah Crunkhorn

https://doi.org/10.1038/d41573-021-00004-y Actions

Targeting tumour-associated bacteria

JOURNAL ARTICLE published December 2023 in Nature Reviews Drug Discovery

Authors: Sarah Crunkhorn

https://doi.org/10.1038/d41573-023-00176-9 Actions

Bacteria tag tumours for CAR-T cell attack

JOURNAL ARTICLE published December 2023 in Nature Reviews Drug Discovery

Authors: M. Teresa Villanueva

https://doi.org/10.1038/d41573-023-00181-y Actions

Repurposing SGLT2 inhibitors

JOURNAL ARTICLE published January 2019 in Nature Reviews Drug Discovery

Authors: Sarah Crunkhorn

https://doi.org/10.1038/nrd.2018.229 Actions

Understanding long-lasting ketamine effects

JOURNAL ARTICLE published December 2023 in Nature Reviews Drug Discovery

Authors: Sarah Crunkhorn

https://doi.org/10.1038/d41573-023-00175-w Actions

The acute myeloid leukaemia market

JOURNAL ARTICLE published April 2020 in Nature Reviews Drug Discovery

Authors: Jorrit Schaefer | Sorcha Cassidy | Rachel M. Webster

https://doi.org/10.1038/d41573-019-00142-4 Actions

Genome editing to 're-write' wrongs

JOURNAL ARTICLE published October 2018 in Nature Reviews Drug Discovery

Authors: Mary Ellen Perry | Kayla M. Valdes | Elizabeth Wilder | Christopher P. Austin | Philip J. Brooks

https://doi.org/10.1038/nrd.2018.91 Actions

Why do oncology drugs fail to gain US regulatory approval?

JOURNAL ARTICLE published July 2015 in Nature Reviews Drug Discovery

Authors: Sean Khozin | Ke Liu | Jonathan P. Jarow | Richard Pazdur

https://doi.org/10.1038/nrd4651 Actions

Fine-tuning antibody–drug conjugates

JOURNAL ARTICLE published March 2014 in Nature Reviews Drug Discovery

Authors: Alexandra Flemming

https://doi.org/10.1038/nrd4266 Actions

Author Correction: Bridging the gap between innovation and later-stage financing for biotech in Europe

JOURNAL ARTICLE published November 2023 in Nature Reviews Drug Discovery

Authors: Jing Gong | Jean-Loup Romet-Lemonne | Brandy Houser

https://doi.org/10.1038/s41573-023-00792-5 Actions

Protein degradation reaches further out

JOURNAL ARTICLE published September 2020 in Nature Reviews Drug Discovery

Authors: M. Teresa Villanueva

https://doi.org/10.1038/d41573-020-00139-4 Actions

Synthesizing portimines

JOURNAL ARTICLE published November 2023 in Nature Reviews Drug Discovery

Authors: Sarah Crunkhorn

https://doi.org/10.1038/d41573-023-00161-2 Actions

Buy buy bispecific antibodies

JOURNAL ARTICLE published November 2011 in Nature Reviews Drug Discovery

Authors: David Holmes

https://doi.org/10.1038/nrd3581 Actions

FDA approves first hypoxia-inducible factor prolyl hydroxylase inhibitor

JOURNAL ARTICLE published March 2023 in Nature Reviews Drug Discovery

Authors: Asher Mullard

https://doi.org/10.1038/d41573-023-00028-6 Actions

Late-stage osteoporosis drugs illustrate challenges in the field

JOURNAL ARTICLE published October 2009 in Nature Reviews Drug Discovery

Authors: Alisa Opar

https://doi.org/10.1038/nrd3015 Actions

Orphan drug designation and development in Japan: 25 years of experience and assessment

JOURNAL ARTICLE published December 2021 in Nature Reviews Drug Discovery

Authors: Ken Sakushima | Hiroshi Takeda | Yoko Aoi

https://doi.org/10.1038/d41573-021-00045-3 Actions

Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention

JOURNAL ARTICLE published 1 April 2004 in Nature Reviews Drug Discovery

Authors: Martin Braddock | Anthony Quinn

https://doi.org/10.1038/nrd1342 Actions

Acyl-lysine reader inhibitor blocks AML progression

JOURNAL ARTICLE published November 2022 in Nature Reviews Drug Discovery

Authors: Sarah Crunkhorn

https://doi.org/10.1038/d41573-022-00160-9 Actions

Identifying selective PI3KC2α inhibitors

JOURNAL ARTICLE published November 2022 in Nature Reviews Drug Discovery

Authors: Sarah Crunkhorn

https://doi.org/10.1038/d41573-022-00161-8 Actions
Feedback: support@crossref.org